We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$120M
AUM Growth
+$15.6M
Cap. Flow
+$15.6M
Cap. Flow %
13.04%
Top 10 Hldgs %
46.75%
Holding
154
New
30
Increased
62
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$2.65M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$895K
3
PGP
PIMCO Global StockPLUS & Income Fund
PGP
+$827K
4
BIIB icon
Biogen
BIIB
+$795K
5
PFE icon
Pfizer
PFE
+$666K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$605K
2
MTW icon
Manitowoc
MTW
+$406K
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$398K
4
AMD icon
Advanced Micro Devices
AMD
+$346K
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$334K

Sector Composition

Rank Sector Weight
1 Healthcare 15.26%
2 Technology 12.31%
3 Communication Services 5.77%
4 Industrials 3.81%
5 Energy 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.88T
$12.9M 10.79%
412,048
+12,940
+3% +$414K
IJH icon
2
iShares Core S&P Mid-Cap ETF
IJH
$123B
$8.1M 6.76%
269,935
+29,340
+12% +$895K
IVW icon
3
iShares S&P 500 Growth ETF
IVW
$72.5B
$7.23M 6.03%
253,884
+4,768
+2% +$138K
IJR icon
4
iShares Core S&P Small-Cap ETF
IJR
$109B
$6.23M 5.2%
105,670
+5,020
+5% +$297K
IVE icon
5
iShares S&P 500 Value ETF
IVE
$48.9B
$5.2M 4.34%
56,429
+1,344
+2% +$127K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$3.91T
$4.82M 4.02%
181,320
+17,090
+10% +$458K
NVO
7
Novo Nordisk
NVO
$216B
$3.6M 3.01%
131,634
+94,336
+253% +$2.65M
PBE icon
8
Invesco Biotechnology & Genome ETF
PBE
$282M
$3.56M 2.97%
61,055
+4,630
+8% +$265K
HYG icon
9
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$2.34M 1.95%
26,323
-3,690
-12% -$334K
GILD icon
10
Gilead Sciences
GILD
$161B
$2M 1.67%
17,074
-547
-3% -$59.8K
LQD icon
11
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$1.94M 1.62%
16,796
-3,357
-17% -$398K
PFF icon
12
iShares Preferred and Income Securities ETF
PFF
$13.2B
$1.82M 1.52%
46,427
+10,402
+29% +$413K
PMF
13
DELISTED
PIMCO Municipal Income Fund
PMF
$1.66M 1.38%
120,320
+9,993
+9% +$148K
NBIX icon
14
Neurocrine Biosciences
NBIX
$17.6B
$1.58M 1.32%
33,091
+606
+2% +$25.7K
FHLC icon
15
Fidelity MSCI Health Care Index ETF
FHLC
$3.27B
$1.52M 1.27%
42,194
+14,651
+53% +$526K
CELG
16
DELISTED
Celgene Corp
CELG
$1.46M 1.22%
12,604
-210
-2% -$24K
REGN icon
17
Regeneron Pharmaceuticals
REGN
$69.1B
$1.37M 1.15%
2,695
+70
+3% +$34.2K
SPXL icon
18
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.57B
$1.23M 1.03%
55,932
-460
-0.8% -$10.7K
EFA icon
19
iShares MSCI EAFE ETF
EFA
$76.5B
$1.21M 1.01%
19,095
-173
-0.9% -$11.5K
PGP
20
PIMCO Global StockPLUS & Income Fund
PGP
$97.1M
$1.21M 1.01%
71,453
+39,579
+124% +$827K
FTEC icon
21
Fidelity MSCI Information Technology Index ETF
FTEC
$19.9B
$1.21M 1.01%
37,647
+12,431
+49% +$409K
ERX icon
22
Direxion Daily Energy Bull 2X ETF
ERX
$250M
$1.15M 0.96%
2,290
+101
+5% +$59.5K
PML
23
PIMCO Municipal Income Fund II
PML
$485M
$1.04M 0.87%
90,915
+983
+1% +$12K
IWC icon
24
iShares Micro-Cap ETF
IWC
$1.44B
$1.04M 0.87%
12,749
-1,119
-8% -$89.9K
PGEN icon
25
Precigen
PGEN
$1.91B
$1.02M 0.85%
21,164
+5,762
+37% +$243K
1
2 3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
PVI
Pine Valley Investments Marlton, New Jersey $2.18B AUM 26.57% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
SQA
Simon Quick Advisors Morristown, New Jersey $2.19B AUM 17.29% 1-Year Est. Return

Traynor Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Traynor Capital Management held 154 positions worth $120M, up 15% from $104M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Traynor Capital Management deployed $15.6M of net new capital in Q2 2015, opening 30 new positions and adding to 62 existing holdings. Its largest new stake was Biogen: 1,980 shares worth $799K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $398K trimmed.

  • Traynor Capital Management's largest Q2 2015 buy was Biogen: 1,980 shares worth $799K.
  • Traynor Capital Management added most to Novo Nordisk in Q2 2015, an estimated $2.65M increase.
  • Traynor Capital Management's biggest Q2 2015 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $398K.
  • Traynor Capital Management fully exited Eli Lilly in Q2 2015, selling an estimated $605K.
  • Traynor Capital Management's ten largest holdings make up 47% of its $120M portfolio in Q2 2015.
  • Traynor Capital Management opened 30 new positions and closed 13 in Q2 2015.
  • Traynor Capital Management's portfolio value rose 15% quarter-over-quarter to $120M.

Based on Traynor Capital Management's 13F filing for Q2 2015, filed 23 Feb 2016.